Evidence for an Important Interaction Between a Complement-Derived CD21 Ligand on Follicular Dendritic Cells and CD21 on B Cells in the Initiation of IgG Responses

The addition of Ags to mononuclear leukocyte cultures typically elicits modest Ab responses, implying that cosignals beyond those provided by T cells and macrophages may be needed. Recently, we reported that Ab responses could be dramatically enhanced (10-1000-fold) by the addition of follicular den...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of immunology (1950) Vol. 161; no. 9; pp. 4549 - 4554
Main Authors Qin, Dahui, Wu, Jiuhua, Carroll, Michael C, Burton, Gregory F, Szakal, Andras K, Tew, John G
Format Journal Article
LanguageEnglish
Published United States Am Assoc Immnol 01.11.1998
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The addition of Ags to mononuclear leukocyte cultures typically elicits modest Ab responses, implying that cosignals beyond those provided by T cells and macrophages may be needed. Recently, we reported that Ab responses could be dramatically enhanced (10-1000-fold) by the addition of follicular dendritic cells (FDC), suggesting that FDC may provide an important costimulatory signal. This result prompted a study of molecules involved in FDC-mediated enhancement of Ab responses stimulated by specific Ag with memory T and B cells or nonspecifically by the addition of LPS. In this study, we report evidence supporting the concept that FDC bear a ligand that engages complement receptor II (CR2 or CD21) on B cells and provides a critical cosignal for both Ag-specific and polyclonal responses. A blockade of the CR2 ligand on FDC by the use of soluble CR2 or a blockade of CR2 on B cells by use of CR2 knockout mice (or B cells with CR2 blocked) reduced Ab responses from the microg/ml to the ng/ml range (10-1000-fold reductions). FDC from C3 knockout mice, which cannot generate the CR2-binding fragments (iC3b, C3d, and C3dg), were unable to provide costimulatory activity, suggesting the CR2 ligand on FDC consists of C3 fragments. FDC trap complement-activating Ag-Ab complexes, and it appears that FDC present B cells with both specific Ag to engage B cell receptors and a CR2 ligand to engage B cell-CR2. In short, optimal induction of specific Ab responses appears to require the combination of specific Ag and costimulatory molecules from both T cells and FDC.
AbstractList The addition of Ags to mononuclear leukocyte cultures typically elicits modest Ab responses, implying that cosignals beyond those provided by T cells and macrophages may be needed. Recently, we reported that Ab responses could be dramatically enhanced (10-1000-fold) by the addition of follicular dendritic cells (FDC), suggesting that FDC may provide an important costimulatory signal. This result prompted a study of molecules involved in FDC-mediated enhancement of Ab responses stimulated by specific Ag with memory T and B cells or nonspecifically by the addition of LPS. In this study, we report evidence supporting the concept that FDC bear a ligand that engages complement receptor II (CR2 or CD21) on B cells and provides a critical cosignal for both Ag-specific and polyclonal responses. A blockade of the CR2 ligand on FDC by the use of soluble CR2 or a blockade of CR2 on B cells by use of CR2 knockout mice (or B cells with CR2 blocked) reduced Ab responses from the mu g/ml to the ng/ml range (10-1000-fold reductions). FDC from C3 knockout mice, which cannot generate the CR2-binding fragments (iC3b, C3d, and C3dg), were unable to provide costimulatory activity, suggesting the CR2 ligand on FDC consists of C3 fragments. FDC trap complement-activating Ag-Ab complexes, and it appears that FDC present B cells with both specific Ag to engage B cell receptors and a CR2 ligand to engage B cell-CR2. In short, optimal induction of specific Ab responses appears to require the combination of specific Ag and costimulatory molecules from both T cells and FDC.
The addition of Ags to mononuclear leukocyte cultures typically elicits modest Ab responses, implying that cosignals beyond those provided by T cells and macrophages may be needed. Recently, we reported that Ab responses could be dramatically enhanced (10-1000-fold) by the addition of follicular dendritic cells (FDC), suggesting that FDC may provide an important costimulatory signal. This result prompted a study of molecules involved in FDC-mediated enhancement of Ab responses stimulated by specific Ag with memory T and B cells or nonspecifically by the addition of LPS. In this study, we report evidence supporting the concept that FDC bear a ligand that engages complement receptor II (CR2 or CD21) on B cells and provides a critical cosignal for both Ag-specific and polyclonal responses. A blockade of the CR2 ligand on FDC by the use of soluble CR2 or a blockade of CR2 on B cells by use of CR2 knockout mice (or B cells with CR2 blocked) reduced Ab responses from the microg/ml to the ng/ml range (10-1000-fold reductions). FDC from C3 knockout mice, which cannot generate the CR2-binding fragments (iC3b, C3d, and C3dg), were unable to provide costimulatory activity, suggesting the CR2 ligand on FDC consists of C3 fragments. FDC trap complement-activating Ag-Ab complexes, and it appears that FDC present B cells with both specific Ag to engage B cell receptors and a CR2 ligand to engage B cell-CR2. In short, optimal induction of specific Ab responses appears to require the combination of specific Ag and costimulatory molecules from both T cells and FDC.
Abstract The addition of Ags to mononuclear leukocyte cultures typically elicits modest Ab responses, implying that cosignals beyond those provided by T cells and macrophages may be needed. Recently, we reported that Ab responses could be dramatically enhanced (10–1000-fold) by the addition of follicular dendritic cells (FDC), suggesting that FDC may provide an important costimulatory signal. This result prompted a study of molecules involved in FDC-mediated enhancement of Ab responses stimulated by specific Ag with memory T and B cells or nonspecifically by the addition of LPS. In this study, we report evidence supporting the concept that FDC bear a ligand that engages complement receptor II (CR2 or CD21) on B cells and provides a critical cosignal for both Ag-specific and polyclonal responses. A blockade of the CR2 ligand on FDC by the use of soluble CR2 or a blockade of CR2 on B cells by use of CR2 knockout mice (or B cells with CR2 blocked) reduced Ab responses from the μg/ml to the ng/ml range (10–1000-fold reductions). FDC from C3 knockout mice, which cannot generate the CR2-binding fragments (iC3b, C3d, and C3dg), were unable to provide costimulatory activity, suggesting the CR2 ligand on FDC consists of C3 fragments. FDC trap complement-activating Ag-Ab complexes, and it appears that FDC present B cells with both specific Ag to engage B cell receptors and a CR2 ligand to engage B cell-CR2. In short, optimal induction of specific Ab responses appears to require the combination of specific Ag and costimulatory molecules from both T cells and FDC.
Author Burton, Gregory F
Carroll, Michael C
Szakal, Andras K
Wu, Jiuhua
Qin, Dahui
Tew, John G
Author_xml – sequence: 1
  fullname: Qin, Dahui
– sequence: 2
  fullname: Wu, Jiuhua
– sequence: 3
  fullname: Carroll, Michael C
– sequence: 4
  fullname: Burton, Gregory F
– sequence: 5
  fullname: Szakal, Andras K
– sequence: 6
  fullname: Tew, John G
BackLink https://www.ncbi.nlm.nih.gov/pubmed/9794381$$D View this record in MEDLINE/PubMed
BookMark eNqFkc9u1DAQxi1UVLaFJ0BIPsEpi5049uYI2f5ZaSUkBGfLcSa7rhI72E6jPg8vitNdUG-cRprvN9-M5rtCF9ZZQOg9JWtGWPX5wQzDZF2_ppyuqzUrWfUKrWhZkoxzwi_QipA8z6jg4g26CuGBEMJJzi7RZSUqVmzoCv2-eTQtWA24cx4ri3fD6HxUNuKdjeCVjsZZ_BXiDGCxwrUbxh4GsDHbgjeP0OJ6m1O8NwdlW5zYW9f3Rk-98ngLtvUmGo1r6PuAF-KZXizPPWNxPELaljj1vMx1eHe4w98hjM4GCG_R6071Ad6d6zX6eXvzo77P9t_udvWXfaaZYDHjjWJsowohNrxluhIURF7RVvCmy1mZRKGajmlSlQ3hWglVsK4si2LTikY1UFyjjyff0btfE4QoBxN0OlJZcFOQIv2vSN_9L0gFJUWeL2BxArV3IXjo5OjNoPyTpEQuGcq_GcqUoazkkmGa-nC2n5oB2n8z59CS_umkH83hOBsPMgyq7xNN5TzPL5z-ANYtqYI
CitedBy_id crossref_primary_10_1146_annurev_immunol_18_1_709
crossref_primary_10_1016_j_vetimm_2006_07_005
crossref_primary_10_1267_ahc_34_265
crossref_primary_10_4049_jimmunol_1900620
crossref_primary_10_1111_j_1365_2567_2004_02075_x
crossref_primary_10_1134_S0006297911050038
crossref_primary_10_1007_s11262_007_0105_0
crossref_primary_10_1016_S0753_3322_03_00084_2
crossref_primary_10_4049_jimmunol_173_11_6676
crossref_primary_10_1016_S1471_4906_01_01942_1
crossref_primary_10_1038_nri2454
crossref_primary_10_1016_S0162_3109_00_80297_0
crossref_primary_10_1128_IAI_73_1_277_286_2005
crossref_primary_10_1093_oxfimm_iqab011
crossref_primary_10_1111_imr_12744
crossref_primary_10_1002_eji_200324147
crossref_primary_10_1007_s00018_022_04303_4
crossref_primary_10_4049_jimmunol_171_11_5975
crossref_primary_10_1128_IAI_69_5_3031_3040_2001
crossref_primary_10_3389_fimmu_2016_00225
crossref_primary_10_4049_jimmunol_167_10_5758
crossref_primary_10_1016_S0192_0561_99_00061_2
crossref_primary_10_4049_jimmunol_177_8_5204
crossref_primary_10_1038_nri1179
crossref_primary_10_1016_j_coi_2005_04_007
crossref_primary_10_1038_nri1178
crossref_primary_10_3109_08923970902845768
crossref_primary_10_1111_j_1365_2567_2010_03252_x
crossref_primary_10_4049_jimmunol_170_7_3671
crossref_primary_10_1016_j_it_2010_03_002
crossref_primary_10_1016_j_clim_2006_07_001
crossref_primary_10_1128_CMR_16_4_597_621_2003
crossref_primary_10_4049_jimmunol_168_6_2782
crossref_primary_10_4049_jimmunol_178_11_7139
crossref_primary_10_1111_imr_12731
crossref_primary_10_4049_jimmunol_174_9_5358
crossref_primary_10_1016_j_vaccine_2008_11_061
crossref_primary_10_1002_1521_4141_200101_31_1_176__AID_IMMU176_3_0_CO_2_H
crossref_primary_10_1016_j_immuni_2008_10_019
crossref_primary_10_1016_j_vaccine_2008_11_062
crossref_primary_10_1078_0344_0338_00421
crossref_primary_10_1007_s00296_004_0541_2
crossref_primary_10_1189_jlb_72_2_249
crossref_primary_10_1016_j_virol_2006_04_018
crossref_primary_10_1016_j_bbrc_2006_05_091
crossref_primary_10_4049_jimmunol_163_12_6442
crossref_primary_10_4049_jimmunol_181_5_2953
crossref_primary_10_3109_08830180109045588
crossref_primary_10_1007_s00296_007_0503_6
crossref_primary_10_1002_eji_201545739
crossref_primary_10_1016_j_imlet_2021_06_006
crossref_primary_10_1038_ncomms4989
crossref_primary_10_4049_jimmunol_164_12_6268
crossref_primary_10_1242_jcs_02984
crossref_primary_10_1007_s00296_008_0604_x
crossref_primary_10_12998_wjcc_v7_i3_373
crossref_primary_10_1128_CVI_00465_07
crossref_primary_10_1016_j_arr_2003_08_002
crossref_primary_10_1016_S0165_2427_01_00369_5
crossref_primary_10_4049_jimmunol_179_7_4444
crossref_primary_10_1038_86562
crossref_primary_10_1111_j_1600_0765_2005_00829_x
crossref_primary_10_1016_S0002_9440_10_65165_6
crossref_primary_10_1111_j_0300_9475_2004_01494_x
crossref_primary_10_4049_jimmunol_167_6_3190
crossref_primary_10_4049_jimmunol_167_9_5052
crossref_primary_10_1016_j_jim_2006_03_018
crossref_primary_10_1016_S0145_2126_00_00107_7
crossref_primary_10_1016_j_imlet_2007_12_007
crossref_primary_10_1016_j_coi_2009_05_013
crossref_primary_10_4049_jimmunol_0802317
crossref_primary_10_3389_fonc_2020_01422
crossref_primary_10_1016_j_molimm_2009_08_016
crossref_primary_10_1016_j_coi_2017_03_001
crossref_primary_10_1159_000083356
Cites_doi 10.4049/jimmunol.141.8.2569
10.4049/jimmunol.150.1.31
10.3181/00379727-121-30760
10.1002/eji.1830270102
10.1002/eji.1830161008
10.4049/jimmunol.134.3.1360
10.4049/jimmunol.146.12.4071
10.1126/science.280.5363.582
10.1126/science.1373518
10.1146/annurev.iy.13.040195.001015
10.4049/jimmunol.131.4.1714
10.1084/jem.181.6.1985
10.1016/0167-5699(89)90258-2
10.1016/S1074-7613(00)80433-1
10.1006/smim.1994.1039
10.1084/jem.183.4.1857
10.1038/newbio237157a0
10.1111/j.1365-2249.1993.tb05904.x
10.1038/icb.1979.40
10.1111/j.1600-065X.1992.tb00633.x
10.1084/jem.172.2.665
10.1038/358505a0
10.1615/CritRevImmunol.v17.i1.40
10.1073/pnas.93.8.3357
10.1084/jem.127.2.277
10.4049/jimmunol.144.5.1640
10.1126/science.1718035
10.1084/jem.140.1.126
10.1007/BF00177584
10.4049/jimmunol.157.8.3404
10.4049/jimmunol.148.8.2331
10.4049/jimmunol.159.5.2116
10.1111/j.1600-0765.1987.tb02062.x
10.1016/0952-7915(95)80009-3
10.4049/jimmunol.140.2.341
10.1126/science.271.5247.348
10.4049/jimmunol.147.1.224
10.1002/eji.1830250836
10.1002/ar.1092270411
10.1002/eji.1830211029
10.1002/jlb.39.6.617
10.4049/jimmunol.157.2.549
10.1016/0014-4800(68)90007-5
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7T5
H94
7X8
DOI 10.4049/jimmunol.161.9.4549
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Immunology Abstracts
AIDS and Cancer Research Abstracts
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
AIDS and Cancer Research Abstracts
Immunology Abstracts
MEDLINE - Academic
DatabaseTitleList AIDS and Cancer Research Abstracts
MEDLINE - Academic
CrossRef
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1550-6606
EndPage 4554
ExternalDocumentID 10_4049_jimmunol_161_9_4549
9794381
www161_9_4549
Genre Research Support, U.S. Gov't, P.H.S
Journal Article
Comparative Study
GrantInformation_xml – fundername: NIAID NIH HHS
  grantid: AI-17142
GroupedDBID -
08R
2WC
34G
39C
3O-
53G
55
5GY
5RE
5VS
79B
85S
8RP
AALRV
AARDX
ABEFU
ABFLS
ABOCM
ABPPZ
ABPTK
ACGFS
ACIWK
ACNCT
ACPRK
ADACO
ADBBV
ADKFC
AENEX
AETEA
AFFNX
AFRAH
AJYGW
ALMA_UNASSIGNED_HOLDINGS
BAWUL
D0L
DIK
DU5
E3Z
EBS
EJD
F5P
FH7
FRP
G8K
GJ
GX1
IH2
J5H
K-O
K78
KQ8
L7B
MVM
MYA
NEJ
O0-
OK1
P0W
P2P
PQEST
PQQKQ
R.V
RHF
RHI
RZQ
SJN
TWZ
VH1
WH7
WOQ
X
X7M
XFK
XJT
YCJ
ZA5
ZE2
ZGI
ZXP
---
-~X
.55
.GJ
18M
ABCQX
ABJNI
ACGFO
ADNWM
AFHIN
AFOSN
AHWXS
AI.
AIZAD
BTFSW
CGR
CUY
CVF
ECM
EIF
NPM
TR2
W8F
XSW
XTH
YHG
AAYXX
CITATION
7T5
H94
7X8
ID FETCH-LOGICAL-c474t-6ba448a37786d4c971e7291d76bf245a447abf4c095b06ca7a34f55338d7babe3
ISSN 0022-1767
IngestDate Sat Aug 17 01:43:55 EDT 2024
Fri Aug 16 04:17:07 EDT 2024
Thu Sep 26 16:59:33 EDT 2024
Sat Sep 28 07:41:55 EDT 2024
Tue Nov 10 19:22:50 EST 2020
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c474t-6ba448a37786d4c971e7291d76bf245a447abf4c095b06ca7a34f55338d7babe3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
OpenAccessLink https://journals.aai.org/jimmunol/article-pdf/161/9/4549/1095273/im219804549o.pdf
PMID 9794381
PQID 17103220
PQPubID 23462
PageCount 6
ParticipantIDs proquest_miscellaneous_70003550
proquest_miscellaneous_17103220
crossref_primary_10_4049_jimmunol_161_9_4549
pubmed_primary_9794381
highwire_smallpub1_www161_9_4549
ProviderPackageCode RHF
RHI
PublicationCentury 1900
PublicationDate 19981101
1998-Nov-01
1998-11-01
PublicationDateYYYYMMDD 1998-11-01
PublicationDate_xml – month: 11
  year: 1998
  text: 19981101
  day: 01
PublicationDecade 1990
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle The Journal of immunology (1950)
PublicationTitleAlternate J Immunol
PublicationYear 1998
Publisher Am Assoc Immnol
Publisher_xml – name: Am Assoc Immnol
References 2022123114342017400_R7
2022123114342017400_R41
2022123114342017400_R6
2022123114342017400_R40
2022123114342017400_R9
2022123114342017400_R8
2022123114342017400_R3
2022123114342017400_R2
2022123114342017400_R5
2022123114342017400_R4
2022123114342017400_R19
2022123114342017400_R18
2022123114342017400_R17
2022123114342017400_R39
2022123114342017400_R16
2022123114342017400_R38
2022123114342017400_R15
2022123114342017400_R37
2022123114342017400_R1
2022123114342017400_R14
2022123114342017400_R36
2022123114342017400_R13
2022123114342017400_R35
2022123114342017400_R12
2022123114342017400_R34
2022123114342017400_R11
2022123114342017400_R33
2022123114342017400_R10
2022123114342017400_R32
2022123114342017400_R31
2022123114342017400_R30
2022123114342017400_R29
2022123114342017400_R28
2022123114342017400_R27
2022123114342017400_R26
2022123114342017400_R25
2022123114342017400_R24
2022123114342017400_R23
2022123114342017400_R45
2022123114342017400_R22
2022123114342017400_R44
2022123114342017400_R21
2022123114342017400_R43
2022123114342017400_R20
2022123114342017400_R42
References_xml – ident: 2022123114342017400_R13
– ident: 2022123114342017400_R33
  doi: 10.4049/jimmunol.141.8.2569
– ident: 2022123114342017400_R20
  doi: 10.4049/jimmunol.150.1.31
– ident: 2022123114342017400_R27
  doi: 10.3181/00379727-121-30760
– ident: 2022123114342017400_R37
  doi: 10.1002/eji.1830270102
– ident: 2022123114342017400_R39
  doi: 10.1002/eji.1830161008
– ident: 2022123114342017400_R18
  doi: 10.4049/jimmunol.134.3.1360
– ident: 2022123114342017400_R8
  doi: 10.4049/jimmunol.146.12.4071
– ident: 2022123114342017400_R22
– ident: 2022123114342017400_R38
  doi: 10.1126/science.280.5363.582
– ident: 2022123114342017400_R31
  doi: 10.1126/science.1373518
– ident: 2022123114342017400_R14
  doi: 10.1146/annurev.iy.13.040195.001015
– ident: 2022123114342017400_R25
  doi: 10.4049/jimmunol.131.4.1714
– ident: 2022123114342017400_R35
  doi: 10.1084/jem.181.6.1985
– ident: 2022123114342017400_R26
  doi: 10.1016/0167-5699(89)90258-2
– ident: 2022123114342017400_R4
  doi: 10.1016/S1074-7613(00)80433-1
– ident: 2022123114342017400_R10
  doi: 10.1006/smim.1994.1039
– ident: 2022123114342017400_R42
  doi: 10.1084/jem.183.4.1857
– ident: 2022123114342017400_R41
  doi: 10.1038/newbio237157a0
– ident: 2022123114342017400_R34
  doi: 10.1111/j.1365-2249.1993.tb05904.x
– ident: 2022123114342017400_R24
  doi: 10.1038/icb.1979.40
– ident: 2022123114342017400_R9
  doi: 10.1111/j.1600-065X.1992.tb00633.x
– ident: 2022123114342017400_R44
  doi: 10.1084/jem.172.2.665
– ident: 2022123114342017400_R23
  doi: 10.1038/358505a0
– ident: 2022123114342017400_R1
  doi: 10.1615/CritRevImmunol.v17.i1.40
– ident: 2022123114342017400_R5
  doi: 10.1073/pnas.93.8.3357
– ident: 2022123114342017400_R12
  doi: 10.1084/jem.127.2.277
– ident: 2022123114342017400_R32
  doi: 10.4049/jimmunol.144.5.1640
– ident: 2022123114342017400_R7
  doi: 10.1126/science.1718035
– ident: 2022123114342017400_R40
  doi: 10.1084/jem.140.1.126
– ident: 2022123114342017400_R36
  doi: 10.1007/BF00177584
– ident: 2022123114342017400_R15
  doi: 10.4049/jimmunol.157.8.3404
– ident: 2022123114342017400_R17
  doi: 10.4049/jimmunol.148.8.2331
– ident: 2022123114342017400_R43
  doi: 10.4049/jimmunol.159.5.2116
– ident: 2022123114342017400_R3
  doi: 10.1111/j.1600-0765.1987.tb02062.x
– ident: 2022123114342017400_R2
  doi: 10.1016/0952-7915(95)80009-3
– ident: 2022123114342017400_R29
  doi: 10.4049/jimmunol.140.2.341
– ident: 2022123114342017400_R30
  doi: 10.1126/science.271.5247.348
– ident: 2022123114342017400_R6
  doi: 10.4049/jimmunol.147.1.224
– ident: 2022123114342017400_R21
  doi: 10.1002/eji.1830250836
– ident: 2022123114342017400_R28
  doi: 10.1002/ar.1092270411
– ident: 2022123114342017400_R45
  doi: 10.1002/eji.1830211029
– ident: 2022123114342017400_R19
  doi: 10.1002/jlb.39.6.617
– ident: 2022123114342017400_R16
  doi: 10.4049/jimmunol.157.2.549
– ident: 2022123114342017400_R11
  doi: 10.1016/0014-4800(68)90007-5
SSID ssj0006024
Score 1.9573077
Snippet The addition of Ags to mononuclear leukocyte cultures typically elicits modest Ab responses, implying that cosignals beyond those provided by T cells and...
Abstract The addition of Ags to mononuclear leukocyte cultures typically elicits modest Ab responses, implying that cosignals beyond those provided by T cells...
SourceID proquest
crossref
pubmed
highwire
SourceType Aggregation Database
Index Database
Publisher
StartPage 4549
SubjectTerms Animals
Antibody Formation
B-Lymphocytes - immunology
Complement C3 - deficiency
Complement C3 - genetics
Complement C3 - pharmacology
Complement C3 - physiology
Complement System Proteins - immunology
Dendritic Cells - immunology
Female
Immunoglobulin G - biosynthesis
Lymphocyte Activation
Mice
Mice, Inbred BALB C
Mice, Inbred C57BL
Mice, Knockout
Receptors, Complement 3d - immunology
Title Evidence for an Important Interaction Between a Complement-Derived CD21 Ligand on Follicular Dendritic Cells and CD21 on B Cells in the Initiation of IgG Responses
URI http://www.jimmunol.org/cgi/content/abstract/161/9/4549
https://www.ncbi.nlm.nih.gov/pubmed/9794381
https://search.proquest.com/docview/17103220
https://search.proquest.com/docview/70003550
Volume 161
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1db9MwFLXKEIgXBIOJ8ekHeIKUJHXi5pGtaze0DiG1Ut8sO3G2opKiLaGCf4P4o9wbO06ATXy8RJV766Q6J_a919fHhDwPcx3EqdKen2K2CsvbpRqk3jDnQQbeHDgFmIecnsSHc_Z2ES16vW-dqqWqVP3066X7Sv4HVWgDXHGX7D8g6zqFBvgM-MIVEIbrX2HcHAlqSyFR6he96aI0iT57DPieLcWS9ctvysW9ETzfZ8zujsIAAvNTzJ-D7Rg1uk1p6kgXWX0Owst9vVoZKefaGru0bbZI8ggrkJzveXQ6wVUBLL21BYofWkp2HOAlbk0xElAv6oU2v5OWeG-0DUbyrFq6iaOqObeszqq2vghFJM3SybTN-O5V53ZbwMSWLmdup1_gEhvtRoOAm9M63GAdBx1WJp2hl0VG-9RO4ywy4tS_ThEMQiKcIux_7EOH_aTf_rgryH3yToznx8didrCYXSPXQ55EGN9PFm0VUeyHrBGkx2c1wlZ4k9eX3OJn56cRpL46uKmdnNkdctuCQ98Yqt0lPV1skxvmvNIv2-Tm1FZi3CPfG-5R4B6VBXXcox3uUcs9Kunv3KPIJmq4R8G25R513KM1zyha1NbYpW1bFhS4R1vu0XVOgXvUce8-mY8PZvuHnj3ww0sZZ6UXK8nYUA5Q0zBjacIDDbEfjBmxykMWwZdcqpylEBYoP04llwOWRxCwDDOupNKDHbJVrAv9gNAU3K4IfNFkiL_iLMlV6GcylSzRgJPeJa8aJMQno-siIB5G4EQDnADgRCIQuF1CG7TExUe5WgFKgdhsNl2TZw2KAoZoXHeThV5XFyLgqFoZ-ldb8HpFPwKLHQO_e6YEBRyHwcM_dv6I3Gpfosdkqzyv9BPwl0v1tGbsD9yywMw
link.rule.ids 315,786,790,27957,27958
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evidence+for+an+Important+Interaction+Between+a+Complement-Derived+CD21+Ligand+on+Follicular+Dendritic+Cells+and+CD21+on+B+Cells+in+the+Initiation+of+IgG+Responses&rft.jtitle=The+Journal+of+immunology+%281950%29&rft.au=Qin%2C+Dahui&rft.au=Wu%2C+Jiuhua&rft.au=Carroll%2C+M+C&rft.au=Burton%2C+G+F&rft.date=1998-11-01&rft.issn=0022-1767&rft.volume=161&rft.issue=9&rft.spage=4549&rft.epage=4554&rft_id=info:doi/10.4049%2Fjimmunol.161.9.4549&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-1767&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-1767&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-1767&client=summon